Literature DB >> 8770044

Endotoxin stimulates lymphocyte-endothelial interactions in rat intestinal Peyer's patches and villus mucosa.

S Miura1, Y Tsuzuki, I Kurose, M Suematsu, T Shigematsu, H Kimura, H Higuchi, H Serizawa, H Yagita, K Okumura, D N Granger, H Ishii.   

Abstract

Although lymphocyte-endothelial cell interactions represent a key step in controlling the recruitment of lymphocytes into gut-associated tissues, its dynamic process in microvessels of lymphoid (Peyer's patches) and nonlymphoid (villus) regions of the small bowel remains poorly understood. We monitored the migration of fluorescence-labeled T lymphocytes into normal and lipopolysaccharide (LPS)-inflamed rat intestinal microvessels using intravital microscopy. In Peyer's patches, T lymphocytes selectively adhered to postcapillary venules, although such selectivity was not observed in submucosal venules of villi. T lymphocytes exhibited rolling behavior followed by firm adhesion in microvessels of both the Peyer's patches and the villi, with both types of adhesive interaction being mediated by alpha 4-integrins. The enhanced rolling and adherence of lymphocytes observed in Peyer's patches and submucosal venules of villi of LPS-treated rats were preceded by a reduction in shear rate and were mediated largely by alpha 4-integrins and partly by beta 2-integrins. In capillaries of intestinal mucosa, lymphocyte adherence occurred without rolling and was independent of alpha 4-integrins. LPS also significantly increased adherence of lymphocytes to villus capillaries, which was not mediated by either alpha 4- or beta 2-integrin. These observations demonstrate significant heterogeneity of lymphocyte-endothelial cell interactions within different regions of the intestinal mucosa.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8770044     DOI: 10.1152/ajpgi.1996.271.2.G282

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

1.  In vivo demonstration of T lymphocyte migration and amelioration of ileitis in intestinal mucosa of SAMP1/Yit mice by the inhibition of MAdCAM-1.

Authors:  K Matsuzaki; Y Tsuzuki; H Matsunaga; T Inoue; J Miyazaki; R Hokari; Y Okada; A Kawaguchi; S Nagao; K Itoh; S Matsumoto; S Miura
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

2.  Effect of specific antigen stimulation on intraepithelial lymphocyte migration to small intestinal mucosa.

Authors:  S Komoto; S Miura; S Koseki; M Goto; S Hachimura; H Fujimori; R Hokari; Y Hara; T Ogino; C Watanabe; H Nagata; S Kaminogawa; T Hibi; H Ishii
Journal:  Clin Exp Immunol       Date:  2005-05       Impact factor: 4.330

3.  Involvement of mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in the pathogenesis of granulomatous colitis in rats.

Authors:  R Hokari; S Kato; K Matsuzaki; A Iwai; A Kawaguchi; S Nagao; T Miyahara; K Itoh; E Sekizuka; H Nagata; H Ishii; T Iizuka; M Miyasaka; S Miura
Journal:  Clin Exp Immunol       Date:  2001-11       Impact factor: 4.330

4.  Endotoxin stimulates monocyte-endothelial cell interactions in mouse intestinal Peyer's patches and villus mucosa.

Authors:  N Ishii; Y Tsuzuki; K Matsuzaki; J Miyazaki; Y Okada; R Hokari; A Kawaguchi; S Nagao; K Itoh; S Miura
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

5.  Anti-inflammatory effects of the genus Bifidobacterium on macrophages by modification of phospho-I kappaB and SOCS gene expression.

Authors:  Yoshikiyo Okada; Yoshikazu Tsuzuki; Ryota Hokari; Shunsuke Komoto; Chie Kurihara; Atsushi Kawaguchi; Shigeaki Nagao; Soichiro Miura
Journal:  Int J Exp Pathol       Date:  2009-04       Impact factor: 1.925

Review 6.  The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics.

Authors:  Carlos R Camara-Lemarroy; Luanne Metz; Jonathan B Meddings; Keith A Sharkey; V Wee Yong
Journal:  Brain       Date:  2018-07-01       Impact factor: 13.501

7.  Molecular mechanisms of lymphocyte homing to peripheral lymph nodes.

Authors:  R A Warnock; S Askari; E C Butcher; U H von Andrian
Journal:  J Exp Med       Date:  1998-01-19       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.